Labiotech.eu

cambridge epigenix true methyl oxsb seq epigenome sequencing 5mc 5hmc gv sequoia geoff smith

News and Trends 14 Mar 2016

British Startup Raises Millions to Become the Illumina for Epigenetics

Cambridge Epigenetix (UK) wants to unlock the power of the Epigenome and become what Illumina is for NGS. And now, it has gotten the €18.9M and a new CEO needed to achieve this. Cambrige Epigenetix is a Biotech developing epigenetic tools, and was initially founded by Cambridge Enterprise (an incubator of the University of Cambridge) and […]

March 14, 2016 - 3 minutesmins - By Denise Neves Gameiro

zika mosquito oxitcec fda swarm florida trial genetic engineering infectious disease

News and Trends 14 Mar 2016

Florida to release Genetically Engineered Mosquitoes to stop Zika Virus

Oxitec (UK) is on track to be allowed to trial their self-limiting, genetically engineered mosquitoes in the US – and stop the spread of Dengue and Zika. As a spin-off from Oxford University, Oxitec specialises in using genetic engineering to control insect pest populations with the ‘Sterile Insect Technique’. This is an interesting alternative to pesticides […]

March 14, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 14 Mar 2016

5 Steps to Transform your Laboratory into an Automated Workspace!

Today’s laboratories work with a range of information sources – from samples, results, tests, storage, budget, client’s requests and so on. In this way, information finds itself at the heart of a lab, and is crucial for efficient research. Automation and digitalization of the workspace can therefore help labs to manage this large amount of information. Labiotech, in collaboration […]

March 14, 2016 - 7 minutesmins - By Joachim Eeckhout

News and Trends 14 Mar 2016

DBV: “These Additional Results Confirm our Potential of solving the Peanut Allergy problem Worldwide”

DBV Technologies (Paris) was just under the spotlight in Los Angeles at the biggest allergy convention worldwide (2016 AAAAI Annual Meeting). Their Viaskin skin patch could potentially eradicate peanut allergies for patients altogether… Last year, it was the first French Biotech to be listed on the NASDAQ (raising €90M), it then raised €255M (!) in a follow-up round […]

March 14, 2016 - 6 minutesmins - By Philip Hemme

News and Trends 12 Mar 2016

What happened this week? 5 Berlin Biotechs, Cancer Infographic, EMA Fast Track

Monday: Infographic: The Top 8 Deadliest Cancers and Who in Biotech is Fighting Them Tuesday: 5 Biotech Companies you Should know in Berlin Wednesday: EMA Launches its own Fast Track for Breakthrough Therapies Thursday: The Largest Scandinavian Biotech Fundraising of 2016 has just been Signed Friday: Interview: Can this Natural Acid replace Petroleum for the […]

March 12, 2016 - 1 minutemin - By Philip Hemme

katharina unger julia kaisinger bioart fungi mutarium design geography bioart design

News and Trends 12 Mar 2016

Recycling can be Delicious! Austrian BioArt Designers transform Plastic Waste into Edible Mushrooms

You read that right. Austrian designers Katharina Unger and Julia Kaisinger have developed a device that turns polymer waste into edible mushrooms in collaboration with researchers from Utrecht University in the Netherlands. Dinner is served! Take a few seconds to have a look around and count how many items near you have plastic components. From your laptop to […]

March 12, 2016 - 3 minutesmins - By Lourdes Riquelme

genfit nash fatty liver disease elfibranor PPAR phase III resolve it

News and Trends 11 Mar 2016

Genfit Has Enroled its First Patient in a NASH Phase III Trial

Genfit (France) has enroled their first patient in the highly anticipated phase III trial (RESOLVE-IT) for NASH, a fatty-liver disease currently without any approved treatment. This is good news for Genfit, which managed to kickstart a phase III trial for their lead candidate, Elafibranor, just one year after the read-out of the phase IIb results. There […]

March 11, 2016 - 2 minutesmins - By Denise Neves Gameiro

nature cancer reviews lumd leiden isa pharmaceuticals immuno oncology immunotherapies checkpointblocking chemotherapy immunosupression

News and Trends 11 Mar 2016

Reviewing Immuno-Oncology: What works and what doesn’t

Researchers from Leiden University Medical Center (LUMC) and ISA Pharmaceuticals (Netherlands) have authored an extensive review of what is working in immuno-oncology – and what hasn’t. The review was accepted in the well-known journal Nature Reviews Cancer and it covers the findings of 250 peer-reviewed papers about immunotherapies. Immuno-oncology is radically changing the way cancer is being […]

March 11, 2016 - 4 minutesmins - By Denise Neves Gameiro

italy milano gfbiochemicals levulinic acid petroleum chemicals biofuels pisa segetis

News and Trends 11 Mar 2016

Interview: Can this Natural Acid replace Petroleum for the Chemical and Biofuel Industries?

GFBiochemicals in (Italy) is producing levulinic acid (from breakdown of biomass) to replace petroleum-based products for a huge range of sectors, with up to a $30Bn market volume. We had the chance to meet Marcel Van Berkel, the CMO of GFBiochemicals, which is based in Milan with additional Netherlands and Minnesota (US) sites. Berkel told us more about the many […]

March 11, 2016 - 4 minutesmins - By Marie Godar

News and Trends 11 Mar 2016

Biotech of the Week: Mission Therapeutics and a Cambridge Pathway against Cancer

From East to West, this week we say goodbye to Hungary and head up towards Queen Elizabeth II’s United Kingdom. Cambridge, known for its World renowned Academia is where Mission Therapeutics, our Biotech of the Week is located. City: Cambridge (UK) Founded: 2011 Employees: 30 Total raised: €110M (as of 02/2016) CEO: Anker Lundemose Mission: Founded in 2011, Mission Therapeutics, […]

March 11, 2016 - 1 minutemin - By Joachim Eeckhout

capella biosciences medicxi ventures advent life sciences osage university partners mabs monoclonal antibodies oncology autoimmune target biology

News and Trends 10 Mar 2016

Antibody Start-up Gets a Slice of a Rebranded €210M Life Sciences Fund

Capella Biosciences (UK) is a life sciences start-up specializing in antibodies. It has just raised an additional €14.3M in a Series A round to develop their antibody pipeline to clinical stages. Capella started out in 2014 and based in London, defining its mission as developing therapeutic monoclonal antibodies for unmet medical needs. Back then, it received […]

March 10, 2016 - 2 minutesmins - By Denise Neves Gameiro

aprea ovarian cancer p53 protein apr 246 karolinska versant ventures 5am ventures healthcap

News and Trends 10 Mar 2016

The Largest Scandinavian Biotech Fundraising of 2016 has just been Signed

Aprea (Sweden) is not a well-know Biotech (yet), but has succeeded in raising €46M from big investors in the US and Europe. Why? For its First-in-class potential for a famous cancer target… Aprea started in 2003 as a spin-off from cancer research at Karolinska Institutet, in its technology-transfer program. This Biotech has a promising candidate […]

March 10, 2016 - 3 minutesmins - By Denise Neves Gameiro

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

British Startup Raises Millions to Become the Illumina for Epigenetics

Florida to release Genetically Engineered Mosquitoes to stop Zika Virus

5 Steps to Transform your Laboratory into an Automated Workspace!

DBV: “These Additional Results Confirm our Potential of solving the Peanut Allergy problem Worldwide”

What happened this week? 5 Berlin Biotechs, Cancer Infographic, EMA Fast Track

Recycling can be Delicious! Austrian BioArt Designers transform Plastic Waste into Edible Mushrooms

Genfit Has Enroled its First Patient in a NASH Phase III Trial

Reviewing Immuno-Oncology: What works and what doesn’t

Interview: Can this Natural Acid replace Petroleum for the Chemical and Biofuel Industries?

Biotech of the Week: Mission Therapeutics and a Cambridge Pathway against Cancer

Antibody Start-up Gets a Slice of a Rebranded €210M Life Sciences Fund

The Largest Scandinavian Biotech Fundraising of 2016 has just been Signed

Subscribe to our newsletter to get the latest biotech news!